Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG

Approved

STANDARD

EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG

Swan Pond Investments Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Aug 10, 2020
Approval ID: f4bd90aa7a786d4c
Company: Swan Pond Investments Limited
Type: Standard

Approval Details

Approval Id: f4bd90aa7a786d4c
Drug Cima Aemps Name: EVEROLIMUS SWANPOND INVESTMENTS 5 MG COMPRIMIDOS EFG
Register Number: 85346
Holder Company Name: Swan Pond Investments Limited
Marketing Company Name: Swan Pond Investments Limited
Authorization Date: 2020-08-10
Dosage Form: COMPRIMIDO
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Swan Pond Investments Limited

Active Ingredients

EVEROLIMUS

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 10, 2020

Approval ID

f4bd90aa7a786d4c

Type

Standard

Back to CIMA-AEMPS Approvals